02/14/2024 1:25 PM | ARMISTICE CAPITAL, LLC (Filed by) CNS Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/06/2024 9:26 AM | CNS Pharmaceuticals (Issuer) Mahery Amy (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
02/06/2024 9:27 AM | Climaco John M (Reporting) CNS Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2024 9:27 AM | CNS Pharmaceuticals (Issuer) Downs Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2024 9:27 AM | CNS Pharmaceuticals (Issuer) Evans Carl Anthony (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2024 9:28 AM | CNS Pharmaceuticals (Issuer) Gumulka Jerzy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2024 9:28 AM | CNS Pharmaceuticals (Issuer) Mahery Amy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
02/02/2024 4:00 PM | CNS Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/31/2024 3:27 PM | CNS Pharmaceuticals (Filer)
| Form 424B4 | |
01/29/2024 11:15 PM | CNS Pharmaceuticals (Filer)
| Form EFFECT | |
01/23/2024 3:01 PM | CNS Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/22/2024 5:02 AM | CNS Pharmaceuticals (Filer)
| Form S-1/A | |
01/10/2024 4:26 PM | CNS Pharmaceuticals (Filer)
| Form S-1/A | |
12/21/2023 8:15 AM | CNS Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2023 7:36 AM | CNS Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/08/2023 4:28 PM | CNS Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
11/30/2023 11:15 PM | CNS Pharmaceuticals (Filer)
| Form EFFECT | |
11/30/2023 4:20 PM | CNS Pharmaceuticals (Filer)
| Form 424B3 | |
11/21/2023 8:11 PM | CNS Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/20/2023 4:26 PM | CNS Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
11/15/2023 7:00 AM | CNS Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/18/2023 8:00 AM | CNS Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/17/2023 7:00 AM | CNS Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/12/2023 5:00 PM | Andraczke Andrzej (Reporting) CNS Pharmaceuticals (Issuer)
| Form 4/A | |
10/12/2023 5:00 PM | Charles Faith L. (Reporting) CNS Pharmaceuticals (Issuer)
| Form 4/A | |
10/12/2023 5:00 PM | CNS Pharmaceuticals (Issuer) Cockroft Bettina M. (Reporting)
| Form 4/A | |
10/12/2023 5:01 PM | CNS Pharmaceuticals (Issuer) Keyes Jeffry R. (Reporting)
| Form 4/A | |
10/12/2023 5:01 PM | CNS Pharmaceuticals (Issuer) Evans Carl Anthony (Reporting)
| Form 4/A | |
10/12/2023 5:01 PM | CNS Pharmaceuticals (Issuer) Gumulka Jerzy (Reporting)
| Form 4/A | |
09/25/2023 5:20 PM | Andraczke Andrzej (Reporting) CNS Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2023 5:20 PM | Charles Faith L. (Reporting) CNS Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2023 5:21 PM | CNS Pharmaceuticals (Issuer) Cockroft Bettina M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2023 5:24 PM | CNS Pharmaceuticals (Issuer) Evans Carl Anthony (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2023 5:26 PM | CNS Pharmaceuticals (Issuer) Gumulka Jerzy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2023 5:27 PM | CNS Pharmaceuticals (Issuer) Keyes Jeffry R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2023 6:51 PM | CNS Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/23/2023 7:00 AM | CNS Pharmaceuticals (Issuer) Downs Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/18/2023 4:25 PM | CNS Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/15/2023 7:30 AM | CNS Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2023 4:12 PM | CNS Pharmaceuticals (Filer)
| Form DEF 14A | |
08/14/2023 8:25 AM | CNS Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Major Elon Musk Crypto Leak Revealed (Ad) Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market.
Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account."
Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. |
08/14/2023 6:34 AM | CNS Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023 8:14 PM | CNS Pharmaceuticals (Issuer) Cockroft Bettina M. (Reporting)
| Form 4/A | |
05/15/2023 7:35 AM | CNS Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/15/2023 7:36 AM | CNS Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2023 7:45 AM | CNS Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/01/2023 5:59 PM | CNS Pharmaceuticals (Issuer) Downs Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/01/2023 5:59 PM | Climaco John M (Reporting) CNS Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/21/2023 6:58 AM | CNS Pharmaceuticals (Issuer) Gumulka Jerzy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/18/2023 7:00 AM | CNS Pharmaceuticals (Issuer) Downs Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2023 7:17 AM | CNS Pharmaceuticals (Issuer) Gumulka Jerzy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/14/2023 3:20 PM | Climaco John M (Reporting) CNS Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/31/2023 6:28 PM | CNS Pharmaceuticals (Issuer) Downs Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/31/2023 6:28 PM | Climaco John M (Reporting) CNS Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |